Mepolizumab Is Efficacious in Patients With Chronic Obstructive Pulmonary Disease Regardless of Disease Duration: Post Hoc Analysis of the MATINEE Phase III Randomized Controlled Trial

Authors: N. Roche, I.D. Pavord, F.C. Sciurba, J. Bourbeau, J. Min, S. Kolterer, B. Mayer, S. Gould, F.J. Martinez

Published: 2025-05-11

DOI: 10.1164/ajrccm.2025.211.abstracts.a5560

Source: Full article


Abstract

No abstract found.